Current status of management of cognitive function in patients with multimorbidity

HAN Yue; YANG Zhenhua; HAN Qingfeng; XIAO Weizhong

doi:10.16766/j.cnki.issn.1674-4152.003129

Volume 21 Issue 8

Aug. 2023

Turn off MathJax

Article Contents

Article Navigation > Chinese Journal of General Practice > 2023 > 21(8): 1388-1392

HAN Yue, YANG Zhenhua, HAN Qingfeng, XIAO Weizhong. Current status of management of cognitive function in patients with multimorbidity[J]. Chinese Journal of General Practice, 2023, 21(8): 1388-1392. doi: 10.16766/j.cnki.issn.1674-4152.003129

Citation:

HAN Yue, YANG Zhenhua, HAN Qingfeng, XIAO Weizhong. Current status of management of cognitive function in patients with multimorbidity[J]. Chinese Journal of General Practice, 2023, 21(8): 1388-1392. doi: 10.16766/j.cnki.issn.1674-4152.003129

Citation:

PDF( 482 KB)

Current status of management of cognitive function in patients with multimorbidity

doi: 10.16766/j.cnki.issn.1674-4152.003129

1.
Department of General Medicine, Peking University Third Hospital, Beijing 100191, China

Funds:

B-YXGP20210201-01

Received Date: 2022-06-14
Available Online: 2023-09-13

Abstract

Abstract

With the increasing ageing of the population, the problem of multimorbidity is becoming more and more serious, and the multimorbidity has also become a major cause of cognitive impairment. Indeed, the two are interrelated. Without a comprehensive approach, it is easy to create a vicious circle in both directions. The mechanisms of the interaction between multimorbidity and cognitive impairment are unclear, which may be related to accelerated ageing and its chronic inflammation and oxidative stress, so more basic research is needed to clarify these views. Because of multimorbidity, problems such as polypharmacy, potentially inappropriate drug use, drug-drug interactions, and the effects of drugs on cognitive function are public health issues that general practitioners need to address. Cognitive function screening, assessment and active intervention measures in patients with multimorbidity, and comprehensive management including non-drug treatment, drug treatment, psycho-psychology and rehabilitation, will definitely prevent or reduce the occurrence of cognitive dysfunction in patients with multimorbidity. Slowing the progression of cognitive impairment. Unfortunately, the current management of cognitive function in patients with multimorbidity mainly follows the previous assessment and treatment of cognitive dysfunction without considering the impact of multimorbidity. Therefore, there is an urgent need to establish and improve guidelines for the management of the cognitive function in patients with multimorbidity. With the continuous improvement of the hierarchical diagnosis and treatment system, general practitioners will surely shoulder the burden of cognitive function management of patients with multimorbidity. While improving our own capabilities, we need to strengthen the initial screening, assessment, intervention, reassessment, and re-intervention of such patients, which truly reflects the continuous management of multimorbidity by general practitioners.
- Multimorbidity,
- Chronic diseases,
- Cognitive function,
- Health management

FullText(HTML)

References(45)

References

[1]	刘帅帅, 张露文, 陆翘楚, 等. 中国中老年人多重慢性病现状调查与健康损失因素探究: 基于CHARLS 2018数据[J]. 实用医学杂志, 2021, 37(4): 518-524. doi: 10.3969/j.issn.1006-5725.2021.04.020 LIU S S, ZHANG L W, CHU Q C, et al. The prevalence of multi-morbidity and related functional limitation among middle-aged and senior population in China: nationally evidence from CHARLS 2018[J]. The Journal of Practical Medicine, 2021, 37(4): 518-524. doi: 10.3969/j.issn.1006-5725.2021.04.020
[2]	BOERSMA P, BLACK L I, WARDD B W. Prevalence of multiple chronic conditionsamong US adults, 2018[J]. Prev Chronic Dis, 2020, 17: 106.
[3]	DUGRAVOT A, FAYOSSE A, DUMURGIER J, et al. Social inequalities in multimorbidity, frailty, disability, and transitions to mortality: a 24-year follow-up of the Whitehall Ⅱ cohort study[J]. Lancet Public Health, 2020, 5(1): 42-50. doi: 10.1016/S2468-2667(19)30226-9
[4]	CHUA Y P, XIE Y, LEE P S S, et al. Definitions and prevalence of multimorbidity in large database studies: a scoping review[J]. Int J Environ Res Public Health, 2021, 18(4): 1673. doi: 10.3390/ijerph18041673
[5]	KADAMBI S, ABDALLAH M, LOH K P. Multimorbidity, function, and cognition in aging[J]. Clin Geriatr Med, 2020, 36(4): 569-584. doi: 10.1016/j.cger.2020.06.002
[6]	中国痴呆与认知障碍指南写作组, 中国医师协会神经内科医师分会认知障碍疾病专业委员会. 2018中国痴呆与认知障碍诊治指南(一): 痴呆及其分类诊断标准[J]. 中华医学杂志, 2018, 98(13): 965-970. doi: 10.3760/cma.j.issn.0376-2491.2018.13.003 China Dementia and Congnitive Impairment Guidelines Writing Group, Chinese Medical Doctor Association Neurology Branch Cognitive Impairment Disease Professional Commttee. 2018 Chinese dementia and cognitive impairment diagnosis and treatment guidelines (1): dementia and its classification and diagnostic criteria[J]. National Medical Journal of China, 2018, 98(13): 965-970. doi: 10.3760/cma.j.issn.0376-2491.2018.13.003
[7]	KASPRZAK D, RZEZNICZAK J, GANOWICZ T, et al. A review of acute coronary syndrome and its potential impact on cognitive function[J]. Glob Heart, 2021, 16(1): 53. doi: 10.5334/gh.934
[8]	XU-LU X Y, YANG Y, CUI D. Association between blood pressure control status, visit-to-visit blood pressure variability, and cognitive function in elderly Chinese: a nationwide study[J]. Front Public Health, 2022, 10: 877192. DOI: 10.3389/fpubh.2022.877192.
[9]	WEDEGÄRTNER S M, BÖHM M, KINDERMANN I. Cognitive dysfunction in heart failure-causes and sequelae[J]. Internist (Berl), 2020, 61(9): 929-938. doi: 10.1007/s00108-020-00835-8
[10]	ZHAO M, JIANG C, LAI Y, et al. Association between atrial fibrillation and domain-specific cognitive decline-insights from the systolic blood pressure intervention trial[J]. Circ J, 2022. DOI: 10.1253/circj.CJ-22-0224.
[11]	CASAGRANDE S S, LEE C, STOECKEL L E, et al. Cognitive function among older adults with diabetes and prediabetes, NHANES 2011-2014[J]. Diabetes Res Clin Pract, 2021, 178: 108939. DOI: 10.1016/j.diabres.2021.108939.
[12]	ZHANG C, WANG Y, LI S, et al. Infarct location and cognitive change in patients after acute ischemic stroke: the ICONS study[J]. J Neurol Sci, 2022, 438: 120276. DOI: 10.1016/j.jns.2022.120276.
[13]	MURTAZA A, DASGUPTA I. Chronic kidney disease and cognitive impairment[J]. J Stroke Cerebrovasc Dis, 2021, 30(9): 105529. DOI: 10.1016/j.jstrokecerebrovasdis.2020.105529.
[14]	SIMARGI Y, MANSYUR M, TURANA Y, et al. Risk of developing cognitive impairment on patients with chronic obstructive pulmonary disease: a systematic review[J]. Medicine (Baltimore), 2022, 101(25): e29235. DOI: 10.1097/MD.0000000000029235.
[15]	VANEK J, PRASKO J, GENZOR S, et al. Obstructive sleep apnea, depression and cognitive impairment[J]. Sleep Med, 2020, 72: 50-58. doi: 10.1016/j.sleep.2020.03.017
[16]	CHOW Y Y, VERDONSCHOT M, MCEVOY C T, et al. Associations between depression and cognition, mild cognitive impairment and dementia in persons with diabetes mellitus: a systematic review and meta-analysis[J]. Diabetes Res Clin Pract, 2022, 185: 109227. DOI: 10.1016/j.diabres.2022.109227.
[17]	LEE Y, CHO Y, OH H. Multiple chronic conditions and risk of cognitive impairment and dementia among older Americans: findings from the Aging, Demographics, and Memory Study (ADAMS)[J]. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 2021, 28(4): 493-507. doi: 10.1080/13825585.2020.1790492
[18]	VASSILAKI M, AAKRE J A, KREMERS W K, et al. The association of multimorbidity with preclinical AD stages and SNAP in cognitively unimpaired persons[J]. J Gerontol A Biol Sci Med Sci, 2019, 74(6): 877-883. doi: 10.1093/gerona/gly149
[19]	WEI M Y, EVINE D A, L ZAHODNE L B, et al. Multimorbidity and cognitive decline over 14 years in older Americans[J]. J Gerontol A Biol Sci Med Sci, 2020, 75(6): 1206-1213. doi: 10.1093/gerona/glz147
[20]	LEE Y, CHO C C. Examining the effects of multiple chronic conditions on cognitive decline and potential moderators among older Koreans: findings from the Korean longitudinal study of ageing 2006-2016[J]. Arch Gerontol Geriatr, 2021, 95: 104424. DOI: 10.1016/j.archger.2021.104424.
[21]	SHANG X W, ZHU Z T, ZHANG X L, et al. Association of a wide range of chronic diseases and apolipoprotein E4 genotype with subsequent risk of dementia in community-dwelling adults: a retrospective cohort study[J]. EClinical Medicine, 2022, 45: 101335. DOI: 10.1016/j.eclinm.2022.101335.
[22]	TAYLOR C A, BOULDIN E D, GREENLUND K J, et al. Comorbid chronic conditions among older adults with subjective cognitive decline, United States, 2015-2017[J]. Innov Aging, 2020, 4(1): igz045. DOI: 10.1093/geroni/igz045.
[23]	张微, 严亚琼, 刘新会, 等. 老年高血压糖尿病高脂血症及其共病对认知功能的影响研究[J]. 中国预防医学杂志, 2021, 22(6): 411-417. doi: 10.16506/j.1009-6639.2021.06.003 ZHANG W, YAN Y Q, LIU X H, et al. The impact of hypertension, diabetes, hyperlipidemia and the comorbidities on cognitive function in the elderly[J]. Chinese Preventive Medicine, 2021, 22(6): 411-417. doi: 10.16506/j.1009-6639.2021.06.003
[24]	HILL N L, BHARGAVA S, BROWN M J, et al. Cognitive complaints in age-related chronic conditions: a systematic review[J]. PLoS One, 2021, 16(7): e0253795. DOI: 10.1371/journal.pone.0253795.
[25]	吴硕琳, 王春雪. 认知功能损伤、痴呆与糖尿病[J]. 中华全科医师杂志, 2018, 17(6): 424-427. doi: 10.3760/cma.j.issn.1671-7368.2018.06.003 WU S H, WANG C X. Cognitive impairment, dementia and diabetes[J]. Chinese Journal of General Practitioners, 2018, 17(6): 424-427. doi: 10.3760/cma.j.issn.1671-7368.2018.06.003
[26]	SADARANGANI T, PERISSINOTTO C, BOAFO J, et al. Multimorbidity patterns in adult day health center clients with dementia: a latent class analysis[J]. BMC Geriatr, 2022, 22(1): 514. doi: 10.1186/s12877-022-03206-0
[27]	DAVID S K, HELENE A, RONALD C, et al. Alzheimer disease[J]. Nat Rev Dis Primers, 2021, 7(1): 34. doi: 10.1038/s41572-021-00275-0
[28]	刘洁, 孙普阳, 王俊, 等. 阿尔茨海默病的衰老机制和干预策略研究综述[J]. 中国基础科学, 2021, 23(5): 20-31. doi: 10.3969/j.issn.1009-2412.2021.05.003 LIU J, SUN P Y, WANG J, et al. Alzheimer's Disease: Ageing-Related Pathogenesis and Intervention Strategies[J]. China Basic Science, 2021, 23(5): 20-31. doi: 10.3969/j.issn.1009-2412.2021.05.003
[29]	PAPATHANASIOU I V, FRADELOS E C, MALLI F, et al. A systematic review of observational studies assessing the impact of oxidative stress in cognitive decline[J]. Wiad Lek, 2021, 74(8): 1995-2003. doi: 10.36740/WLek202108137
[30]	WETTERLING T. Pathogenesis of multimorbidity-what is known?[J]. Z Gerontol Geriatr, 2021, 54(6): 590-596. doi: 10.1007/s00391-020-01752-z
[31]	EHTEWISH H, ARREDOUANI A, EL-AGNAF O. Diagnostic, prognostic, and mechanistic biomarkers of diabetes mellitus-associated cognitive decline[J]. Int J Mol Sci, 2022, 23(11): 6144. doi: 10.3390/ijms23116144
[32]	CARRIE D P, LESLIA A P, REBECCA C R, et al. Screening for cognitive impairment in older adults: updated evidence report and systematic review for the US preventive services task force[J]. JAMA, 2020, 323(8): 764-785. doi: 10.1001/jama.2019.22258
[33]	中华医学会内分泌学分会. 糖尿病患者认知功能障碍专家共识[J]. 中华糖尿病杂志, 2021, 13(7): 678-694. doi: 10.3760/cma.j.cn115791-20210527-00291 Endocrinology Branch of Chinese Medical Association. Expert consensus on diabetic cognitive dysfunction[J]. Chinese Journal of Diabetes Mellitus, 2021, 13(7): 678-694. doi: 10.3760/cma.j.cn115791-20210527-00291
[34]	中国痴呆与认知障碍诊治指南写作组, 中国医师协会神经内科医师分会认知障碍疾病专业委员会. 2018中国痴呆与认知障碍诊治指南(四): 认知障碍疾病的辅助检查[J]. 中华医学杂志, 2018, 98(15): 1130-1142. doi: 10.3760/cma.j.issn.0376-2491.2018.15.003 China Dementia and Congnitive Impairment Guidelines Writing Group, Chinese Medical Doctor Association Neurology Branch Cognitive Impairment Disease Professional Commttee. 2018 Chinese dementia and cognitive impairment diagnosis and treatment guidelines (4): auxiliary examination for cognitive disorders[J]. National Medical Journal of China, 2018, 98(15): 1130-1142. doi: 10.3760/cma.j.issn.0376-2491.2018.15.003
[35]	张慧, 张韶伟, 于德华, 等. 轻度认知功能障碍的药物治疗研究进展[J]. 中华全科医学, 2019, 17(9): 1571-1574, 1591. doi: 10.16766/j.cnki.issn.1674-4152.001000 ZHANG H, ZHANG S H, YU D H, et al. Recent progress on drug therapy of mild cognitive impairment[J]. Chinese Journal of General Practice, 2019, 17(9): 1571-1574, 1591. doi: 10.16766/j.cnki.issn.1674-4152.001000
[36]	DO D, SCHNITTKER J. Utilization of medications with cognitive impairment side effects and the implications for older adults ' cognitive function[J]. J Aging Health, 2020, 32(9): 1165-1177. doi: 10.1177/0898264319895842
[37]	JI S L, ZHAO X X, ZHU R F, et al. Metformin and the risk of dementia based on an analysis of 396, 332 participants[J]. Ther Adv Chronic Dis, 2022, 13: 20406223221109454. DOI: 10.1177/20406223221109454.
[38]	CUKIERMAN Y T, GERSTEIN H C, COLHOUN H M, et al. Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial[J]. Lancet Neurol, 2020, 19(7): 582-590. doi: 10.1016/S1474-4422(20)30173-3
[39]	熊婷, 唐旻, 刘作良. 老年轻度认知功能障碍的非药物治疗进展[J]. 中国实用神经疾病杂志, 2022, 25(3): 368-375. XIONG T, TANG M, LIU Z L. Progress of non-drug therapy for mild cognitive impairment in elderly[J]. Chinese Journal of Practical Nervous Diseases, 2022, 25(3): 368-375.
[40]	GATES N J, RUTJES A W, DI NISIO M, et al. Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life[J]. Cochrane Database Syst Rev, 2020, 2(2): CD012277. DOI: 10.1002/14651858.CD012277.
[41]	WANG T, GUO Z, DU Y, et al. Effects of Noninvasive Brain Stimulation (NIBS) on cognitive impairment in mild cognitive impairment and Alzheimer disease: a meta-analysis[J]. Alzheimer Dis Assoc Disord, 2021, 35(3): 278-288. doi: 10.1097/WAD.0000000000000464
[42]	李耘, 张亚欣, 马丽娜. 老年人轻度认知功能障碍与抑郁关系的研究进展[J]. 北京医学, 2019, 41(2): 139-141. LI Y, ZHANG Y X, MA L N. Research progress on the relationship between mild cognitive dysfunction and depression in the elderly[J]. Beijing Medical Journal, 2019, 41(2): 139-141.
[43]	MARENOGNI A, RIZZUTO D, FRATIGLIONI L, et al. The effect of a 2- year intervention consisting of diet, physical exercise, cognitive training, and monitoring of vascular risk on chronic morbidity-the FINGER randomized controlled trial[J]. J Am Med Dir Assoc, 2018, 19(4): e1. DOI: 10.1016/j.jamda.2017.09.020.
[44]	张亚君, 刘华, 王朝昕, 等. 上海社区中青年慢性病多病共存现况研究[J]. 中国全科医学, 2021, 24(16): 2034-2038. doi: 10.12114/j.issn.1007-9572.2021.00.046 ZHANG Y J, LIU H, WANG Z X, et al. Community-based Prevalence of the Coexistence of Multiple Chronic Diseases among Young and Middle-aged People in Shanghai[J]. Chinese General Practice, 2021, 24(16): 2034-2038. doi: 10.12114/j.issn.1007-9572.2021.00.046
[45]	戴付敏, 刘思雨, 张希. 社区居家多病共存老年人的非正式照料研究进展[J]. 中华全科医学, 2020, 18(3): 471-475. doi: 10.16766/j.cnki.issn.1674-4152.001276 DAI F M, LIU S Y, ZHANG X. Research Progress on informal care of the elderly living with multiple disease in a community home[J]. Chinese Journal of General Practice, 2020, 18(3): 471-475. doi: 10.16766/j.cnki.issn.1674-4152.001276

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (145) PDF downloads(14)

Current status of management of cognitive function in patients with multimorbidity

doi: 10.16766/j.cnki.issn.1674-4152.003129

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content